AMP2
LIVE

Serial Number

98843894

Owner

Theradaptive, Inc.

Attorney

Aaron D. Hendelman

Filing Date

Nov 8, 2024

Add to watchlist:

No watchlists yet
View on USPTO

AMP2 Trademark

Serial Number: 98843894

AMP2 is a trademark filed by Theradaptive, Inc. on November 8, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Theradaptive, Inc. (9 trademarks)

7495 New Horizon Way, Suite 240
Frederick, MD 21703

Entity Type: 03

Trademark Details

Filing Date

November 8, 2024

Registration Date

Not Registered

Published for Opposition

September 9, 2025

Goods & Services

Therapeutic proteins in the nature of bone morphogenetic proteins for use as a bone growth media for medical purposes, namely, the manufacture of implantable medical devices; Therapeutic proteins in the nature of bone morphogenetic proteins for medical use in vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, extremities repair, craniomaxillofacial repair, chemotherapeutics, and sports medicine; pharmaceutical and medicinal preparations and substances for the treatment and prevention of bone and tissue diseases and disorders, musculoskeletal diseases and disorders, blood vessel diseases and damage, craniomaxillofacial diseases and damage, skin diseases and damage, bone and joint injuries, and cancer, namely, therapeutic proteins used for vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, extremities repair, craniomaxillofacial repair, chemotherapeutics, and sports medicine; human allograft bone and tissue

Research and development in connection with protein therapies for use in pharmaceutical products; medical research and product development in the fields of biotechnology, drug discovery, pharmaceuticals, scientific research, and protein therapeutics; development of therapeutics, namely, pharmaceutical and medical therapies for use in vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, extremities repair, craniomaxillofacial repair, chemotherapeutics, and sports medicine; scientific research and development; research and development of medical devices, apparatus, and implants for use in vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, extremities repair, craniomaxillofacial repair, chemotherapeutics, and sports medicine

targetable bone morphogenetic proteins for use as an inducer of regenerative bone growth other than for medical or veterinary purposes

Implantable scaffolds comprising synthetic materials for maintaining tissue contour; implants consisting of synthetic materials; synthetic bone grafts; implants comprising natural, non-living materials; implantable scaffolds comprising synthetic materials, namely, fusion cages for spinal surgery and expandable spinal implants; bone void fillers comprised of synthetic materials; bone regeneration matrices being artificial biomaterials for augmentation of bone for medical purposes; soft tissue regeneration matrices being surgical implants and mesh made of synthetic materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies; implantable medical devices to regenerate, repair, or treat soft tissue and bone; medical and surgical devices, apparatus, and instruments for use in bone and joint surgery, regeneration, reconstruction, and augmentation; artificial biomaterials for augmentation of bone for medical purposes, namely, synthetic materials for use in bone and joint surgery, bone regeneration, and bone reconstruction; bone implants composed of synthetic materials; implantable synthetic materials for surgical repair, regeneration, reconstruction, and augmentation of human tissue; artificial biomaterials for augmentation of tissue for medical purposes, namely, non-living tissue substitutes for use in human tissue repair, regeneration, and reconstruction; synthetic implantable medical devices for the regeneration of bone defects

Filing History

EXTENSION OF TIME TO OPPOSE RECEIVED
Oct 6, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 3, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 8, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 8, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 8, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 8, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 8, 2025 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 12, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 12, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 12, 2025 CNRT
ASSIGNED TO EXAMINER
May 6, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 4, 2025 NWOS
NEW APPLICATION ENTERED
Nov 8, 2024 NWAP